---
title: "CICC Remains a Buy on Everest Medicines Ltd. (1952)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281703087.md"
description: "In a report released yesterday, from CICC maintained a Buy rating on Everest Medicines Ltd., with a price target of HK$55.00.End of Quarter Sale - 50% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Currently, the analyst consensus on Everest Medicines Ltd. is a Moderate Buy with an average price target of HK$55.00."
datetime: "2026-04-05T05:25:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281703087.md)
  - [en](https://longbridge.com/en/news/281703087.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281703087.md)
---

# CICC Remains a Buy on Everest Medicines Ltd. (1952)

In a report released yesterday, from CICC maintained a Buy rating on Everest Medicines Ltd., with a price target of HK$55.00.

### End of Quarter Sale - 50% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Currently, the analyst consensus on Everest Medicines Ltd. is a Moderate Buy with an average price target of HK$55.00.

### Related Stocks

- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [159570.CN](https://longbridge.com/en/quote/159570.CN.md)
- [159102.CN](https://longbridge.com/en/quote/159102.CN.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [516820.CN](https://longbridge.com/en/quote/516820.CN.md)
- [513060.CN](https://longbridge.com/en/quote/513060.CN.md)
- [159567.CN](https://longbridge.com/en/quote/159567.CN.md)
- [01952.HK](https://longbridge.com/en/quote/01952.HK.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [159992.CN](https://longbridge.com/en/quote/159992.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [159892.CN](https://longbridge.com/en/quote/159892.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [513700.CN](https://longbridge.com/en/quote/513700.CN.md)
- [159859.CN](https://longbridge.com/en/quote/159859.CN.md)
- [588860.CN](https://longbridge.com/en/quote/588860.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [159615.CN](https://longbridge.com/en/quote/159615.CN.md)
- [159506.CN](https://longbridge.com/en/quote/159506.CN.md)
- [560600.CN](https://longbridge.com/en/quote/560600.CN.md)
- [588250.CN](https://longbridge.com/en/quote/588250.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)

## Related News & Research

- [11:14 ETRibo y Boehringer Ingelheim siguen avanzando en su programa de siRNA](https://longbridge.com/en/news/285402650.md)
- [Onco-Innovations Announces Inka Health Collaborative Research to Advance Oncology Evidence Generation | ONNVF Stock News](https://longbridge.com/en/news/285274936.md)
- [Grand Pharmaceutical Moves to Adopt New Bye-Laws Aligned With HK Paperless Regime](https://longbridge.com/en/news/284576690.md)
- [07:55 ETSupport Egg Quality and Ovulation with Nature's Bounty® New Fertility Supplement*](https://longbridge.com/en/news/285200796.md)
- [Kepler Capital  Sticks to Its Buy Rating for Affluent Medical SA (0JZ)](https://longbridge.com/en/news/285294988.md)